Literature DB >> 12592303

12. Primary immunodeficiency diseases.

Francisco A Bonilla1, Raif S Geha.   

Abstract

Although primary immunodeficiency disorders are relatively rare, intensive investigation of these disorders has yielded a great wealth of understanding of basic immunologic mechanisms in host defense, inflammation, and autoimmunity. These advances have led to important developments for the treatment not only of the primary immunodeficiencies but also for patients with secondary immunocompromised states, autoimmune disorders, hypersensitivity, graft rejection, and graft versus host disease. Correction of a form of severe combined immunodeficiency represents the first true success of human gene therapy. This review introduces the major clinical manifestations of primary immunodeficiency disorders, along with descriptions of essential elements of the pathophysiology of those disorders that have been defined at the molecular level. Key concepts in treatment are also presented. It is critical for the practicing primary care provider and allergist to maintain an index of suspicion for immunodeficiency. Early diagnosis offers the best opportunity for reduced morbidity and survival and is critical for accurate genetic counseling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12592303     DOI: 10.1067/mai.2003.86

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  29 in total

1.  Primary immune deficiencies presenting in adults: seven years of experience from Iran.

Authors:  Davood Mansouri; Parisa Adimi; Mehdi Mirsaedi; Nahal Mansouri; Payam Tabarsi; Majid Amiri; Hamid R Jamaati; Masoud Motavasseli; Noushin Baghaii; Ali Cheraghvandi; Reza Rouhi; Navid A Roozbahany; Soheila Zahirifard; Forouzan Mohammadi; Mohammad R Masjedi; Ali A Velayati; Jean L Casanova; David P Speert; R Kevin Elwood; Robert Schellenberg; Stuart E Turvey
Journal:  J Clin Immunol       Date:  2005-07       Impact factor: 8.317

2.  Immune globulin subcutaneous (human) vivaglobin: for the treatment of primary immunodeficiency diseases.

Authors: 
Journal:  P T       Date:  2009-06

3.  Deficient synthesis of class-switched, HIV-neutralizing antibodies to the CD4 binding site and correction by electrophilic gp120 immunogen.

Authors:  Stephanie A Planque; Yukie Mitsuda; Vida Chitsazzadeh; Santhi Gorantla; Larisa Poluektova; Yasuhiro Nishiyama; Christina Ochsenbauer; Mary-Kate Morris; Gopal Sapparapu; Carl V Hanson; Richard J Massey; Sudhir Paul
Journal:  AIDS       Date:  2014-09-24       Impact factor: 4.177

4.  Immunophenotypic profiles for distinguishing orbital mucosa-associated lymphoid tissue lymphoma from benign lymphoproliferative tumors.

Authors:  Shunichiro Ueda; Yoshihiko Usui; Takeshi Nagai; Daniel Diaz-Aguilar; Toshitaka Nagao; Hiroshi Goto
Journal:  Jpn J Ophthalmol       Date:  2017-04-18       Impact factor: 2.447

5.  Primary Immunodeficiency Diseases in Aguascalientes, Mexico: Results from an Educational Program.

Authors:  Aristoteles Alvarez-Cardona; Sara Elva Espinosa-Padilla; Saul Oswaldo Lugo Reyes; Javier Ventura-Juarez; Jaime Asael Lopez-Valdez; Lucila Martínez-Medina; Alberto Santillan-Artolozaga; Adriana Cajero-Avelar; Alma R De Luna-Sosa; Luis F Torres-Bernal; Francisco J Espinosa-Rosales
Journal:  J Clin Immunol       Date:  2016-02-22       Impact factor: 8.317

Review 6.  Should newborns be screened for immunodeficiency?: lessons learned from infants with recurrent otitis media.

Authors:  Yesim Yilmaz-Demirdag
Journal:  Curr Allergy Asthma Rep       Date:  2011-12       Impact factor: 4.806

7.  Correction of canine X-linked severe combined immunodeficiency by in vivo retroviral gene therapy.

Authors:  Suk See Ting-De Ravin; Douglas R Kennedy; Nora Naumann; Jeffrey S Kennedy; Uimook Choi; Brian J Hartnett; Gilda F Linton; Narda L Whiting-Theobald; Peter F Moore; William Vernau; Harry L Malech; Peter J Felsburg
Journal:  Blood       Date:  2005-12-29       Impact factor: 22.113

Review 8.  Clinical immunology in practice, new opportunities.

Authors:  Mark R Stein
Journal:  Clin Rev Allergy Immunol       Date:  2004-10       Impact factor: 8.667

9.  Primary Immunodeficiency Diseases in Oman: 10-Year Experience in a Tertiary Care Hospital.

Authors:  Salem Al-Tamemi; Shafiq Ur Rehman Naseem; Nabila Al-Siyabi; Ibtisam El-Nour; Abdulhakim Al-Rawas; David Dennison
Journal:  J Clin Immunol       Date:  2016-10-03       Impact factor: 8.317

Review 10.  Immunoglobulin replacement therapy in children.

Authors:  Maria Garcia-Lloret; Sean McGhee; Talal A Chatila
Journal:  Immunol Allergy Clin North Am       Date:  2008-11       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.